UNSPSC 51172426: Atropine/diphenoxylate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA208. This VA Drug Class (GA208) classifies this compound as belonging to the group ANTIDIARRHEAL AGENTS.

UNSPSC 51172426 Atropine/diphenoxylate is a Commodity code whose recent activity reflects broader state and local procurement of pharmaceutical products and drug-testing services rather than atropine or diphenoxylate specifically. State and local issuing bodies under this code span county departments of community supervision and corrections, state health and human services agencies, and multistate cooperative purchasing alliances. The kinds of work being solicited include offender drug-screening and confirmation testing (immunoassay with LC/MS/MS or GC/MS confirmation), generic pharmaceutical distribution through authorized wholesalers, and exploratory solicitations for direct-to-manufacturer prescription programs. Collin County Community Supervision and Corrections Department (Texas) issued RFP 2026-327 for offender specimen collection and drug testing services with a response deadline of July 23, 2026 and an estimated contract value of $600,000 over two years; the scope encompasses staffing collection sites in Plano and McKinney, operation of an Interactive Voice Response system for randomized testing notifications, and alternative testing methodologies including oral fluid and hair testing. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, requiring vendors to supply through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.

Recent activity concentrates in Texas and Minnesota, with the Texas Health and Human Services Commission also posting an exploratory Request for Information (RFI HHS0017013 in April 2026) on direct-to-manufacturer prescription programs. The Collin County RFP emphasizes vendor lab certification from SAMHSA, TX DPS, or CAP, compliance review and detailed proposal scoring on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 points. The MMCAP RFP requires cGMP certification, Drug Supply Chain Security Act compliance, contractual relationships with at least two of three authorized wholesalers with chargeback systems, and submission through the ePro procurement system; evaluation weights price competitiveness at 75 percent. Neither opportunity names set-aside designations or disadvantaged-enterprise restrictions in the available documentation. The code shows limited recent activity specific to atropine or diphenoxylate as standalone products; procurement under this code reflects state and local acquisition of pharmaceutical testing services and generic drug distribution.